Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2015 (2015), Article ID 193078, 8 pages
http://dx.doi.org/10.1155/2015/193078
Research Article

Polycystic Ovary Syndrome: Aggressive or Protective Factor for the Retina? Evaluation of Macular Thickness and Retinal Nerve Fiber Layers Using High-Definition Optical Coherence Tomography

1Post-Graduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal, RN, Brazil
2Department of Biomedical Sciences, State University of Rio Grande do Norte, Mossoró, RN, Brazil
3Department of Biomedical Sciences, Faculty of Health Sciences, Federal University of Rio Grande do Norte, Central Campus, St. Atirador Miguel Antônio da Silva Neto, s/n, Aeroporto, 59607-360 Mossóro, RN, Brazil
4Department of Surgery, Onofre Lopes University Hospital, Federal University of Rio Grande do Norte, Natal, RN, Brazil
5Department of Obstetrics and Gynecology, Federal University of Rio Grande do Norte, Natal, RN, Brazil
6Department of Clinical and Toxicological Analyses, Federal University of Rio Grande do Norte, Natal, RN, Brazil
7Department of Morphology, Federal University of Rio Grande do Norte, Natal, RN, Brazil

Received 8 October 2014; Revised 17 January 2015; Accepted 19 January 2015

Academic Editor: Hyeong Gon Yu

Copyright © 2015 José Edvan de Souza-Júnior et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. J. Norman, D. Dewailly, R. S. Legro, and T. E. Hickey, “Polycystic ovary syndrome,” The Lancet, vol. 370, no. 9588, pp. 685–697, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. G. D. de Azevedo, E. C. Costa, M. T. A. B. C. Micussi, and J. C. F. de Sá, “Lifestyle modifications in the polycystic ovary syndrome: role of physical exercise and importance of multidisciplinary approach,” Revista Brasileira de Ginecologia e Obstetrícia, vol. 30, no. 5, pp. 261–267, 2008. View at Google Scholar · View at Scopus
  3. E. M. Soares, G. D. Azevedo, and T. M. Maranhao, “Metabolic syndrome in women with polycystic ovary syndrome: prevalence in the city from northeast region of Brazil,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 51, no. 6, pp. 1027–1028, 2007. View at Publisher · View at Google Scholar
  4. J. K. Hillman, L. N. C. Johnson, M. Limaye, R. A. Feldman, M. Sammel, and A. Dokras, “Black women with polycystic ovary syndrome (PCOS) have increased risk for metabolic syndrome and cardiovascular disease compared with white women without PCOS,” Fertility and Sterility, vol. 101, no. 2, pp. 530–535, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. E. M. M. Soares, G. D. Azevedo, R. G. N. Gadelha, T. M. A. M. Lemos, and T. M. O. Maranhão, “Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome,” Fertility and Sterility, vol. 89, no. 3, pp. 649–655, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Apridonidze, P. A. Essah, M. J. Iuorno, and J. E. Nestler, “Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 4, pp. 1929–1935, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. R. S. Legro, V. D. Castracane, and R. P. Kauffman, “Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls,” Obstetrical and Gynecological Survey, vol. 59, no. 2, pp. 141–154, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. W. D. P. Martins, L. F. Santana, C. O. Nastri, F. A. Ferriani, M. F. S. de Sa, and R. M. dos Reis, “Agreement among insulin sensitivity indexes on the diagnosis of insulin resistance in polycystic ovary syndrome and ovulatory women,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 133, no. 2, pp. 203–207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Carmina and R. A. Lobo, “Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome,” Fertility and Sterility, vol. 82, no. 3, pp. 661–665, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Celik, N. Tasdemir, R. Abali, E. Bastu, and M. Yilmaz, “Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study,” Fertility and Sterility, vol. 101, no. 4, pp. 1123.e1–1128.e1, 2014. View at Google Scholar · View at Scopus
  11. D. A. Ehrmann, D. R. Liljenquist, K. Kasza et al., “Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 1, pp. 48–53, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. Y.-A. Sung, J.-Y. Oh, H. Chung, and H. Lee, “Hyperandrogenemia is implicated in both the metabolic and reproductive morbidities of polycystic ovary syndrome,” Fertility and Sterility, vol. 101, no. 3, pp. 840–845, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. Y.-H. Kao, W.-C. Chiu, M.-I. Hsu, and Y.-J. Chen, “Endothelial progenitor cell dysfunction in polycystic ovary syndrome: implications for the genesis of cardiovascular diseases,” International Journal of Fertility and Sterility, vol. 6, no. 4, pp. 208–213, 2013. View at Google Scholar · View at Scopus
  14. H. Zilliacus and B. Nystroem, “Visual disturbance, a symptom in Stein-Leventhal's syndrome,” Acta Obstetricia et Gynecologica Scandinavica, vol. 42, supplement 6, pp. 161–165, 1964. View at Google Scholar · View at Scopus
  15. S. Bonini, F. Mantelli, C. Moretti, A. Lambiase, and A. Micera, “Itchy-dry eye associated with polycystic ovary syndrome,” American Journal of Ophthalmology, vol. 143, no. 5, pp. 763.e2–771.e2, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. G. F. Yavas, F. Ozturk, T. Kusbeci et al., “Meibomian gland alterations in polycystic ovary syndrome,” Current Eye Research, vol. 33, no. 2, pp. 133–138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Coksuer, F. Ozcura, F. Oghan, B. Haliloglu, and S. Karatas, “Effects of hyperandrogenism on tear function and tear drainage in patients with polycystic ovary syndrome,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 56, no. 1-2, pp. 65–70, 2011. View at Google Scholar · View at Scopus
  18. T. Gonen, C. Celik, M. Oznur et al., “Tear osmolarity and ocular surface changes in patient with polycystic ovary syndrome,” Current Eye Research, vol. 38, no. 6, pp. 621–625, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Demir, D. Guven, A. Koc, S. Ozdemir, and E. Can, “Retinal nerve fiber layer thickness in women with polycystic ovary syndrome,” Journal of Ophthalmology, vol. 2013, Article ID 752186, 3 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Acmaz, M. Ata , A. Gulhan, B. Acmaz, F. Ata , and H. Aksoy, “Evaluation of the macula, retinal nerve fiber layer, and choroid thickness in women with polycystic ovary syndrome using spectral-domain optical coherence tomography,” Reproductive Sciences, vol. 21, no. 8, pp. 1044–1049, 2014. View at Publisher · View at Google Scholar
  21. P. D. Gupta, K. Johar Sr., K. Nagpal, and A. R. Vasavada, “Sex hormone receptors in the human eye,” Survey of Ophthalmology, vol. 50, no. 3, pp. 274–284, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. D. N. Koleva-Georgieva and N. P. Sivkova, “Optical coherence tomography for the detection of early macular edema in diabetic patients with retinopathy,” Folia Medica, vol. 52, no. 1, pp. 40–48, 2010. View at Google Scholar · View at Scopus
  23. B. L. Sikorski, G. Malukiewicz, J. Stafiej, H. Lesiewska-Junk, and D. Raczynska, “The diagnostic function of OCT in diabetic maculopathy,” Mediators of Inflammation, vol. 2013, Article ID 434560, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Demir, B. Dirim, Z. Acar, M. Yilmaz, and Y. Sendul, “Cental macular thickness in patients with type 2 diabetes mellitus without clinical retinopathy,” Journal of Ophthalmology, vol. 2013, Article ID 767931, 4 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Y.-L. Park, I. T. Kim, and C. K. Park, “Early diabetic changes in the nerve fibre layer at the macula detected by spectral domain optical coherence tomography,” British Journal of Ophthalmology, vol. 95, no. 9, pp. 1223–1228, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. “Obesity: preventing and managing the global epidemic. Report of a WHO consultation,” World Health Organ Technical Report Series, vol. 894, pp. 1–253, 2000.
  27. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, “Report of the expert committee on the diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 26, supplement 1, pp. S5–S20, 2003. View at Google Scholar
  28. K. G. M. M. Alberti, P. Zimmet, and J. Shaw, “The metabolic syndrome—a new worldwide definition,” The Lancet, vol. 366, no. 9491, pp. 1059–1062, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. K. G. M. M. Alberti, P. Zimmet, and J. Shaw, “Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation,” Diabetic Medicine, vol. 23, no. 5, pp. 469–480, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. “Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report,” Circulation, vol. 106, no. 25, pp. 3143–3421, 2002.
  31. Early Treatment Diabetic Retinopathy Study Research Group, “Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS report number 10,” Ophthalmology, vol. 98, no. 5, supplement, pp. 786–806, 1991. View at Publisher · View at Google Scholar
  32. L. Solé González, R. Abreu González, M. Alonso Plasencia, and P. Abreu Reyes, “Normal macular thickness and volume using spectral domain optical coherence tomography in a reference population,” Archivos de la Sociedad Española de Oftalmología, vol. 88, no. 9, pp. 352–358, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. C. C. A. Sng, C. Y. Cheung, R. E. Man et al., “Influence of diabetes on macular thickness measured using optical coherence tomography: the Singapore Indian Eye Study,” Eye, vol. 26, no. 5, pp. 690–698, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. X. Y. Peng, F. H. Wang, Y. B. Liang et al., “Retinopathy in persons without diabetes: the Handan Eye study,” Ophthalmology, vol. 117, no. 3, pp. 531.e2–537.e2, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. V. S. E. Jeganathan, N. Cheung, W. T. Tay, J. J. Wang, P. Mitchell, and T. Y. Wong, “Prevalence and risk factors of retinopathy in an Asian population without diabetes: the Singapore Malay Eye Study,” Archives of Ophthalmology, vol. 128, no. 1, pp. 40–45, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Ojaimi, T. T. Nguyen, R. Klein et al., “Retinopathy signs in people without diabetes: the multi-ethnic study of atherosclerosis,” Ophthalmology, vol. 118, no. 4, pp. 656–662, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Vujosevic and E. Midena, “Retinal layers changes in human preclinical and early clinical diabetic retinopathy support early retinal neuronal and Müller cells alterations,” Journal of Diabetes Research, vol. 2013, Article ID 905058, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. J. H. Yang, H. W. Kwak, T. G. Kim, J. Han, S. W. Moon, and S. Y. Yu, “Retinal neurodegeneration in type II diabetic Otsuka long-evans Tokushima fatty rats,” Investigative Ophthalmology and Visual Science, vol. 54, no. 6, pp. 3844–3851, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. G. A. Dissen, C. Garcia-Rudaz, A. Paredes, C. Mayer, A. Mayerhofer, and S. R. Ojeda, “Excessive ovarian production of nerve growth factor facilitates development of cystic ovarian morphology in mice and is a feature of polycystic ovarian syndrome in humans,” Endocrinology, vol. 150, no. 6, pp. 2906–2914, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Białek, P. Zaremba, K. K. Borowicz, and S. J. Czuczwar, “Neuroprotective role of testosterone in the nervous system,” Polish Journal of Pharmacology, vol. 56, no. 5, pp. 509–518, 2004. View at Google Scholar · View at Scopus
  41. J. S. Byers, A. L. Huguenard, D. Kuruppu, N.-K. Liu, X.-M. Xu, and D. R. Sengelaub, “Neuroprotective effects of testosterone on motoneuron and muscle morphology following spinal cord injury,” Journal of Comparative Neurology, vol. 520, no. 12, pp. 2683–2696, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. J. S. Perrin, P.-Y. Hervé, G. Leonard et al., “Growth of white matter in the adolescent brain: role of testosterone and androgen receptor,” The Journal of Neuroscience, vol. 28, no. 38, pp. 9519–9524, 2008. View at Publisher · View at Google Scholar · View at Scopus